Optimization and Validation of FePro Cell Labeling Method
Open Access
- 11 June 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (6), e5873
- https://doi.org/10.1371/journal.pone.0005873
Abstract
Current method to magnetically label cells using ferumoxides (Fe)-protamine (Pro) sulfate (FePro) is based on generating FePro complexes in a serum free media that are then incubated overnight with cells for the efficient labeling. However, this labeling technique requires long (>12–16 hours) incubation time and uses relatively high dose of Pro (5–6 µg/ml) that makes large extracellular FePro complexes. These complexes can be difficult to clean with simple cell washes and may create low signal intensity on T2* weighted MRI that is not desirable. The purpose of this study was to revise the current labeling method by using low dose of Pro and adding Fe and Pro directly to the cells before generating any FePro complexes. Human tumor glioma (U251) and human monocytic leukemia cell (THP-1) lines were used as model systems for attached and suspension cell types, respectively and dose dependent (Fe 25 to 100 µg/ml and Pro 0.75 to 3 µg/ml) and time dependent (2 to 48 h) labeling experiments were performed. Labeling efficiency and cell viability of these cells were assessed. Prussian blue staining revealed that more than 95% of cells were labeled. Intracellular iron concentration in U251 cells reached ∼30–35 pg-iron/cell at 24 h when labeled with 100 µg/ml of Fe and 3 µg/ml of Pro. However, comparable labeling was observed after 4 h across the described FePro concentrations. Similarly, THP-1 cells achieved ∼10 pg-iron/cell at 48 h when labeled with 100 µg/ml of Fe and 3 µg/ml of Pro. Again, comparable labeling was observed after 4 h for the described FePro concentrations. FePro labeling did not significantly affect cell viability. There was almost no extracellular FePro complexes observed after simple cell washes. To validate and to determine the effectiveness of the revised technique, human T-cells, human hematopoietic stem cells (hHSC), human bone marrow stromal cells (hMSC) and mouse neuronal stem cells (mNSC C17.2) were labeled. Labeling for 4 hours using 100 µg/ml of Fe and 3 µg/ml of Pro resulted in very efficient labeling of these cells, without impairing their viability and functional capability. The new technique with short incubation time using 100 µg/ml of Fe and 3 µg/ml of Pro is effective in labeling cells for cellular MRI.Keywords
This publication has 18 references indexed in Scilit:
- Quantification of superparamagnetic iron oxide (SPIO)‐labeled cells using MRIJournal of Magnetic Resonance Imaging, 2007
- Cell Internalization of Magnetic Nanoparticles Using Transfection AgentsMolecular Imaging, 2007
- Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticlesNature Protocols, 2006
- Expression of transferrin receptor and ferritin following ferumoxides–protamine sulfate labeling of cells: implications for cellular magnetic resonance imagingNMR in Biomedicine, 2006
- Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cellsNMR in Biomedicine, 2005
- Transfection Agent Induced Nanoparticle Cell LoadingMolecular Imaging, 2005
- Cell Tagging with Clinically Approved Iron Oxides: Feasibility and Effect of Lipofection, Particle Size, and Surface Coating on Labeling EfficiencyRadiology, 2005
- Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRIBlood, 2004
- A comparative analysis of several transformations for enhancement and segmentation of magnetic resonance image scene sequencesIEEE Transactions on Medical Imaging, 1992
- Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years.American Journal of Roentgenology, 1990